BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghosn M, Ibrahim T, Assi T, El Rassy E, Kourie HR, Kattan J. Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. World J Gastroenterol 2016; 22(46): 10124-10130 [PMID: 28028360 DOI: 10.3748/wjg.v22.i46.10124]
URL: https://www.wjgnet.com/1948-5204/full/v22/i46/10124.htm
Number Citing Articles
1
Pan Liu, Jiarui Feng, Meng Sun, Wen Yuan, Ruijing Xiao, Jie Xiong, Xiaoxin Huang, Meng Xiong, Wu Chen, Xin Yu, Qian Sun, Xiaojie Zhao, Qiuping Zhang, Liang Shao. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cellsInternational Journal of Oncology 2017; 51(6): 1878 doi: 10.3892/ijo.2017.4153
2
Zainab L Rai, Veronica Ranieri, Daniel H Palmer, Peter Littler, Pauleh Ghaneh, Kurinchi Gurusamy, Derek Manas, Elena Pizzo, Eftychia Eirini Psarelli, Roopinder Gilmore, Praveen Peddu, David C Bartlett, Nicola de Liguori Carino, Brian R Davidson. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trialBMJ Open 2022; 12(5): e050166 doi: 10.1136/bmjopen-2021-050166
3
Ana Fernández, Mercedes Salgado, Adelaida García, Elvira Buxò, Ruth Vera, Jorge Adeva, Paula Jiménez-Fonseca, Guillermo Quintero, Cristina Llorca, Mamen Cañabate, Luis Jesús López, Andrés Muñoz, Patricia Ramírez, Paula González, Carlos López, Margarita Reboredo, Elena Gallardo, Manuel Sanchez-Cánovas, Javier Gallego, Carmen Guillén, Nuria Ruiz-Miravet, Víctor Navarro-Pérez, Juan De la Cámara, Inmaculada Alés-Díaz, Roberto Antonio Pazo-Cid, Alberto Carmona-Bayonas. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC studyBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5101-3
4
Alex Cazes, Oscar Betancourt, Edgar Esparza, Evangeline S. Mose, Dawn Jaquish, Eric Wong, Alexis A. Wascher, Hervé Tiriac, Marco Gymnopoulos, Andrew M. Lowy. A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic CancerClinical Cancer Research 2021; 27(7): 2100 doi: 10.1158/1078-0432.CCR-20-3210
5
Li-Lian Gan, Ling-Wei Hii, Shew-Fung Wong, Chee-Onn Leong, Chun-Wai Mai. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune EvasionCancers 2020; 12(7): 1872 doi: 10.3390/cancers12071872
6
Rita Khoury, Rebecca Ibrahim, Tony Ibrahim, Axel Le Cesne, Tarek Assi. NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?Future Oncology 2023; 19(9): 617 doi: 10.2217/fon-2023-0088
7
Hamid Bakshi, Mazhar Zoubi, Hakkim Faruck, Alaa Aljabali, Firas Rabi, Amin Hafiz, Khalid Al-Batanyeh, Bahaa Al-Trad, Prawej Ansari, Mohamed Nasef, Nitin Charbe, Saurabh Satija, Meenu Mehta, Vijay Mishra, Gaurav Gupta, Salem Abobaker, Poonam Negi, Ibrahim Azzouz, Ashref Dardouri, Harish Dureja, Parteek Prasher, Dinesh Chellappan, Kamal Dua, Mateus Webba da Silva, Mohamed Tanani, Paul McCarron, Murtaza Tambuwala. Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative DamageNutrients 2020; 12(6): 1901 doi: 10.3390/nu12061901
8
Umme Hani, Riyaz Ali M. Osmani, Ayesha Siddiqua, Shadma Wahab, Sadia Batool, Hissana Ather, Norhan Sheraba, Ali Alqahtani. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancerJournal of Drug Delivery Science and Technology 2021; 63: 102539 doi: 10.1016/j.jddst.2021.102539
9
Daniel Brock Hewitt, Nicholas Nissen, Hassan Hatoum, Benjamin Musher, John Seng, Andrew L. Coveler, Raed Al-Rajabi, Charles J. Yeo, Benjamin Leiby, Joshua Banks, Lodovico Balducci, Gina Vaccaro, Noelle LoConte, Thomas J. George, Warren Brenner, Emad Elquza, Nicholas Vahanian, Gabriela Rossi, Eugene Kennedy, Charles Link, Harish Lavu. A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic CancerAnnals of Surgery 2022; 275(1): 45 doi: 10.1097/SLA.0000000000004669
10
Karl R. Aigner, Sabine Gailhofer, Emir Selak, Kornelia Aigner. Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patientsJournal of Cancer Research and Clinical Oncology 2019; 145(11): 2855 doi: 10.1007/s00432-019-03019-6
11
Daheui Choi, Alan M. Gonzalez‐Suarez, Mihai G. Dumbrava, Michael Medlyn, Jose M. de Hoyos‐Vega, Frank Cichocki, Jeffrey S. Miller, Li Ding, Mojun Zhu, Gulnaz Stybayeva, Alexandre Gaspar‐Maia, Daniel D. Billadeau, Wen Wee Ma, Alexander Revzin. Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and ImmunotherapyAdvanced Science 2024; 11(5) doi: 10.1002/advs.202303088
12
Daria R. Q. de Almeida, Ancély F. dos Santos, Rosangela A. M. Wailemann, Letícia F. Terra, Vinícius M. Gomes, Gabriel S. Arini, Ester R. M. Bertoldi, Eduardo M. Reis, Maurício S. Baptista, Leticia Labriola. Necroptosis activation is associated with greater methylene blue-photodynamic therapy-induced cytotoxicity in human pancreatic ductal adenocarcinoma cellsPhotochemical & Photobiological Sciences 2022; 22(4): 729 doi: 10.1007/s43630-022-00347-4
13
Hui Shan Liew, Chun-Wai Mai, Mohd Zulkefeli, Thiagarajan Madheswaran, Lik Voon Kiew, Lesley Jia Wei Pua, Ling Wei Hii, Wei Meng Lim, May Lee Low. Novel Gemcitabine-Re(I) Bisquinolinyl Complex Combinations and Formulations With Liquid Crystalline Nanoparticles for Pancreatic Cancer Photodynamic TherapyFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.903210
14
Leva Hajatdoost, Keyvan Sedaghat, Erin Walker, Jackson Thomas, Sam Kosari. Chemotherapy in Pancreatic Cancer: A Systematic ReviewMedicina 2018; 54(3): 48 doi: 10.3390/medicina54030048
15
Adam R. Wolfe, Dhivya Prabhakar, Vedat O. Yildiz, Jordan M. Cloyd, Mary Dillhoff, Laith Abushahin, Dayssy Alexandra Diaz, Eric D. Miller, Wei Chen, Wendy L. Frankel, Anne Noonan, Terence M. Williams. Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resectionCancer Medicine 2020; 9(13): 4711 doi: 10.1002/cam4.3075
16
Zahra S. Razaee, Galen Cook‐Wiens, Mourad Tighiouart. A nonparametric Bayesian method for dose finding in drug combinations cancer trialsStatistics in Medicine 2022; 41(6): 1059 doi: 10.1002/sim.9316
17
Junko Tahara, Kyoko Shimizu, Nao Otsuka, Junichi Akao, Yukiko Takayama, Katsutoshi Tokushige. Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancerCancer Chemotherapy and Pharmacology 2018; 82(2): 245 doi: 10.1007/s00280-018-3611-y
18
Huiqin Liu, Mengnan Sun, Zhengsheng Liu, Chao Kong, Weijian Kong, Junxiao Ye, Jianan Gong, David C.S. Huang, Feng Qian. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugsJournal of Controlled Release 2019; 296: 40 doi: 10.1016/j.jconrel.2019.01.014
19
Rebecca Ibrahim, Rita Khoury, Tony Ibrahim, Tarek Assi, Axel Le Cesne. KRAS G12C mutation: from black sheep to key player in pancreatic cancer treatment Future Oncology 2023; 19(7): 485 doi: 10.2217/fon-2023-0067
20
Julien Péron, Joris Giai, Delphine Maucort-Boulch, Marc Buyse. The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic AdenocarcinomaPancreas 2019; 48(2): 275 doi: 10.1097/MPA.0000000000001234
21
Shivang Dhoundiyal, Md. Aftab Alam. Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic Cancer using NanotechnologyCurrent Cancer Drug Targets 2023; 23(9): 697 doi: 10.2174/1568009623666230329085618
22
Melika Rezaee, Jing Wang, Mehdi Razavi, Gang Ren, Fengyan Zheng, Ahmed Hussein, Mujib Ullah, Avnesh S. Thakor. A Study Comparing the Effects of Targeted Intra-Arterial and Systemic Chemotherapy in an Orthotopic Mouse Model of Pancreatic CancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52490-1
23
Guillermo Urrutia, Ann Salmonson, Jorge Toro-Zapata, Thiago M. de Assuncao, Angela Mathison, Nelson Dusetti, Juan Iovanna, Raul Urrutia, Gwen Lomberk. Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork CollapseMolecular Cancer Research 2020; 18(3): 448 doi: 10.1158/1541-7786.MCR-19-0490
24
Benjamin B. Kasten, Abhishek Gangrade, Harrison Kim, Jinda Fan, Soldano Ferrone, Cristina R. Ferrone, Kurt R. Zinn, Donald J. Buchsbaum. 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse modelsNuclear Medicine and Biology 2018; 58: 67 doi: 10.1016/j.nucmedbio.2017.12.004
25
Dimitrios C. Ziogas, Eirini Papadopoulou, Helen Gogas, Stratigoula Sakellariou, Evangellos Felekouras, Charalampos Theocharopoulos, Dimitra T. Stefanou, Maria Theochari, Ioannis Boukovinas, Dimitris Matthaios, Anna Koumarianou, Eleni Zairi, Michalis Liontos, Konstantinos Koutsoukos, Vasiliki Metaxa-Mariatou, George Kapetsis, Angeliki Meintani, Georgios N. Tsaousis, George Nasioulas. Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic DepictionCancers 2023; 16(1): 2 doi: 10.3390/cancers16010002